Filing Details
- Accession Number:
- 0001127602-20-029681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-20 16:12:21
- Reporting Period:
- 2020-11-18
- Accepted Time:
- 2020-11-20 16:12:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1630909 | M. John Griffin | 250 Campus Drive Marlborough MA 01752 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-18 | 22,900 | $39.96 | 157,386 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-18 | 11,321 | $70.80 | 146,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-18 | 11,579 | $71.35 | 134,486 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-11-18 | 22,900 | $0.00 | 22,900 | $39.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-11-05 | No | 4 | M | Direct |
Footnotes
- Includes 43,871 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $70.465 to $71.455 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $71.52 to $71.67 per share. The Reporting Person will provide, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 5, 2015.
Billionaire Hedge Funds
